Edition:
India

Akebia Therapeutics Inc (AKBA.OQ)

AKBA.OQ on NASDAQ Stock Exchange Global Market

15.23USD
23 Feb 2018
Change (% chg)

$0.20 (+1.33%)
Prev Close
$15.03
Open
$15.08
Day's High
$15.26
Day's Low
$14.78
Volume
110,974
Avg. Vol
129,510
52-wk High
$20.25
52-wk Low
$8.60

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 41.28 -0.493
Jun '17 28.52 -0.527
Mar '17 20.86 -1.149
FY 2016 Dec '16 1.53 -0.989
Sep '16 0.00 -0.958
Jun '16 0.00 -0.946
Mar '16 0.00 -0.700
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 4 41.56 54.00 28.00 --
Quarter Ending Jun-18 4 38.44 50.00 28.00 --
Year Ending Dec-18 9 167.16 220.00 122.00 91.52
Earnings (per share)
Quarter Ending Mar-18 4 -0.36 -0.01 -0.59 --
Quarter Ending Jun-18 4 -0.41 -0.25 -0.64 --
Year Ending Dec-18 9 -1.69 -0.53 -3.21 -2.11
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -56.90 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Akebia Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 67.85%
# of Holders: 180
Total Shares Held: 32,070,199
3 Mo. Net Change: 1,497,166
# New Positions: 34
# Closed Positions: 20
# Increased Positions: 105
# Reduced Positions: 63
# Net Buyers: 42
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.